by John Conrad | Sep 15, 2020 | Policy News
The Illinois Biotechnology Innovation Organization, iBIO, opposes the Trump Administration’s decision to move forward with the flawed concept of a “Most Favored Nation” policy that will dramatically affect most vulnerable seniors and patient communities and...
by John Conrad | Sep 1, 2020 | iBIO News, Policy News
Yesterday the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule on Medicare coverage of innovative technologies providing immediate, national coverage of 4 years for breakthroughs through devices. The proposed rule, was the result of many years...
by John Conrad | Aug 26, 2020 | Policy News
iBIO joined with other life sciences state associations in a letter to Department of Health and Human Services Secretary Alex Azar voicing our concern with proposals that would allow the federal government to exercise “march-in rights” on innovative therapeutics or...
by John Conrad | Mar 27, 2020 | iBIO News, Policy News
The Care Act has a number of provisions to support our startup ecosystem in Illinois, including a major small business loan program to help our emerging companies keep the lights on and their employees working during this difficult financial time – loans that, subject...
by John Conrad | Mar 26, 2020 | COVID, Policy News
Title-By-Title Summary Prepared By The Office Of Vice Chairman Leahy (D-Vt.) The appropriations division of the Senate’s bipartisan coronavirus aid and economic relief agreement contains $330 billion in new funding to address the needs of the American people as we...
by John Conrad | Mar 13, 2020 | Policy News
From BIO: The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they have in...
